Suppr超能文献

18号与20号超声引导下细针穿刺在检测头颈部鳞状细胞癌放化疗后持续性淋巴结转移中的比较准确性

Comparative Accuracy of 18-Gauge versus 20-Gauge Ultrasound-Guided Fine-Needle Aspiration in the Detection of Persistent Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma after Chemoradiation.

作者信息

Nguyen Jolee, Patel Dharti, Lano Kinsey, Ansari Shehbaz, Wang Ethan, Yadav Megha, Gillison Maura, Lai Stephen, Fuller C D, Moreno Amy, Gule-Monroe Maria K, Johnson Jason M

机构信息

From the Department of Diagnostic Radiology (J.N., D.P., K.L., E.W., M.K.G.), The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Department of Diagnostic Radiology and Nuclear Medicine (S.A.), Rush University Medical Center, Chicago, IL 60612, USA; Department of Head & Neck Oncology (M.G., A.M.), The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Department of Head & Neck Surgery (S.L.), The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Department of Radiation Oncology (C.D.F.), The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; and Department of Radiology and Biomedical Imaging (M.Y., J.M.J.), Yale University, New Haven, CT 06520, USA.

出版信息

AJNR Am J Neuroradiol. 2025 Aug 28. doi: 10.3174/ajnr.A8990.

Abstract

BACKGROUND AND PURPOSE

Viable malignant disease is uncommon in patients with persistent adenopathy after definitive chemoradiotherapy (CRT) for head & neck squamous cell carcinoma (HNSCC). Preoperative ultrasound-guided fine needle aspiration (USFNA) can prevent unnecessary neck dissection. Post-radiation fibrosis can complicate the approach, resulting in an inadequate aspirate volume when using standard 20 or 22-gauge needles. We assessed the comparative 18 and 20-gauge diagnostic accuracy of USFNA in detecting persistent viable nodal malignancy in patients with HNSCC with nodal metastasis treated with CRT. We hypothesized that 18-gauge USFNA would outperform 20-gauge USFNA in diagnostic accuracy and efficiency.

MATERIALS AND METHODS

We identified a 239-patient cohort (210 males, 60.4±9.8 y) presenting between 2002-2023 with HNSCC and biopsy-proven cervical nodal metastases. All patients were treated with CRT. After CRT, a suspicious nodal remnant underwent biopsy with an 18 or 20-gauge needle. 101 patients received a biopsy with a 20-gauge and 138 received a biopsy with an 18-gauge needle. Biopsy results were compared to either post-biopsy surgical pathology results when available or at least 3 months of computed tomography (CT) follow-up, referred to here as post-USFNA results.

RESULTS

FNA in 181/239 (75.7%) cases showed no evidence of viable metastatic disease on cytology evaluation. 20-gauge cases were performed with 1.36±0.52 passes. 18-gauge cases were performed with 1.26±0.51 passes (p=0.037). A neck dissection was performed within 90 days in 45 patients, while the other 194 patients had follow-up imaging. 40/58 cases were positive concordant (PC) between FNA and post-USFNA results. 177/181 cases were negative concordant (NC) between FNA and post-USFNA results. Overall, USFNA showed a sensitivity of 90.9%, specificity of 90.8%, accuracy of 90.8%, positive predictive value (PPV) of 69.0% and negative predictive value (NPV) of 97.8%. 20-gauge FNA showed PC of 26/39 and NC of 59/62 for a sensitivity of 89.7%, specificity of 81.9%, accuracy of 84.2%, PPV of 66.7% and NPV of 95.2%.18-gauge FNA showed a PC of 14/19 and NC of 118/119 for a sensitivity of 93.3%, specificity of 95.9%, accuracy of 95.7%, PPV of 73.7% and NPV of 99.2%.

CONCLUSIONS

Residual cervical lymph node USFNA after CRT is an accurate procedure with excellent PPV and NPV. 18-gauge USFNA is associated with statistically significant fewer biopsy passes and higher specificity compared to 20-gauge.

ABBREVIATIONS

CRT=chemoradiotherapy; FNA = fine needle aspiration; HNSCC= head & neck squamous cell carcinoma; HPV = human papillomavirus; NC = negative concordant; NPV = negative predictive value; PC = positive concordant; PPV = positive predictive value; SND = salvage neck dissection; USFNA = ultrasound-guided fine needle aspiration.

摘要

背景与目的

在头颈部鳞状细胞癌(HNSCC)接受确定性放化疗(CRT)后出现持续性淋巴结病的患者中,存在存活的恶性疾病并不常见。术前超声引导下细针穿刺抽吸(USFNA)可避免不必要的颈部清扫术。放疗后纤维化会使该方法变得复杂,导致使用标准20或22号针时抽吸量不足。我们评估了18号和20号USFNA在检测接受CRT治疗且有淋巴结转移的HNSCC患者中持续性存活淋巴结恶性肿瘤的诊断准确性。我们假设18号USFNA在诊断准确性和效率方面将优于20号USFNA。

材料与方法

我们确定了一个239例患者的队列(210例男性,年龄60.4±9.8岁),这些患者在2002年至2023年期间出现HNSCC且经活检证实有颈部淋巴结转移。所有患者均接受了CRT治疗。CRT后,对可疑的残留淋巴结用18号或20号针进行活检。101例患者接受了20号针活检,138例患者接受了18号针活检。将活检结果与活检后手术病理结果(若有)或至少3个月的计算机断层扫描(CT)随访结果(在此称为USFNA后结果)进行比较。

结果

181/239例(75.7%)的细针穿刺抽吸(FNA)在细胞学评估中未显示有存活转移性疾病的证据。20号针活检平均进针1.36±0.52次。18号针活检平均进针1.26±0.51次(p = 0.037)。45例患者在90天内进行了颈部清扫术,而其他194例患者进行了随访影像学检查。FNA与USFNA后结果之间有40/58例呈阳性一致(PC)。FNA与USFNA后结果之间有177/181例呈阴性一致(NC)。总体而言,USFNA显示敏感性为90.9%,特异性为90.8%,准确性为90.8%,阳性预测值(PPV)为69.0%,阴性预测值(NPV)为97.8%。20号针FNA显示PC为26/39,NC为59/62,敏感性为89.7%,特异性为81.9%,准确性为84.2%,PPV为66.7%,NPV为95.2%。18号针FNA显示PC为14/19,NC为118/119,敏感性为93.3%,特异性为95.9%,准确性为95.7%,PPV为73.7%,NPV为99.2%。

结论

CRT后残留颈部淋巴结的USFNA是一种准确的操作,具有出色的PPV和NPV。与20号针相比,18号针USFNA在统计学上具有显著更少的活检进针次数和更高的特异性。

缩写

CRT = 放化疗;FNA = 细针穿刺抽吸;HNSCC = 头颈部鳞状细胞癌;HPV = 人乳头瘤病毒;NC = 阴性一致;NPV = 阴性预测值;PC = 阳性一致;PPV = 阳性预测值;SND = 挽救性颈部清扫术;USFNA = 超声引导下细针穿刺抽吸

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验